Anxiety and Depression in Patients with Permanent Atrial Fibrillation: Prevalence and Associated Factors

Maria Polikandrioti, Ioannis Koutelekos, Georgios Vasilopoulos, Georgia Gerogianni, Maritsa Gourni, Sofia Zyga, George Panoutsopoulos, Maria Polikandrioti, Ioannis Koutelekos, Georgios Vasilopoulos, Georgia Gerogianni, Maritsa Gourni, Sofia Zyga, George Panoutsopoulos

Abstract

Atrial fibrillation (AF) is an important public health problem that is increasing at an alarming rate, worldwide. The most common type is permanent AF followed by the paroxysmal and persistent AF. Purpose. This study was aimed at exploring anxiety and depression and the associated factors in patients with permanent AF. Materials and Methods. The sample of the study included 170 AF patients. Data collection was performed by the method of interview using the "Hospital Anxiety and Depression Scale" (HADS) to assess anxiety and depression and a questionnaire including patients' characteristics. Results. 70% of the participants were men, and 32.4% were above 70 years old. Furthermore, 34.9% of the patients had high levels of anxiety, and 20.2% had high levels of depression. Anxiety levels were statistically significantly associated with gender (p=0.022), age (p=0.022), educational level (p=0.025), years having the disease (p=0.005), and relations with nursing staff (p=0.040). Depression levels were statistically significantly associated with age (p=0.037), degree of information of the state of health (p < 0.001), years having the disease (p < 0.001), and relations with medical staff (p=0.041). Conclusions. Patients' characteristics are associated with anxiety and depression and need to be evaluated when treating this frequently encountered arrhythmia.

References

    1. Galli F., Borghi L., Carugo S., et al. Atrial fibrillation and psychological factors: a systematic review. PeerJ. 2017;5:p. e3537. doi: 10.7717/peerj.3537.
    1. Andrikopoulos G., Pastromas S., Mantas I., et al. Management of atrial fibrillation in Greece: the MANAGE-AF study. Hellenic Journal of Cardiology. 2014;55(4):281–287.
    1. Zoni-Berisso M., Lercari F., Carazza T., Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clinical Epidemiology. 2014;6:213–220. doi: 10.2147/clep.s47385.
    1. Wyndham C. R. C. Atrial fibrillation: the most common arrhythmia. Texas Heart Institute Journal. 2000;27(3):257–267.
    1. Bostrom J. A., Saczynski J. S., Hajduk A., et al. Burden of psychosocial and cognitive impairment in patients with atrial fibrillation. Critical Pathways in Cardiology. 2017;16(2):71–75. doi: 10.1097/hpc.0000000000000101.
    1. Lioni L., Vlachos K., Letsas K. P., et al. Differences in quality of life, anxiety and depression in patients with paroxysmal atrial fibrillation and common forms of atrioventricular reentry supraventricular tachycardias. Indian Pacing and Electrophysiology Journal. 2014;14(5):250–257. doi: 10.1016/s0972-6292(16)30796-3.
    1. McCabe P. J. Psychological distress in patients diagnosed with atrial fibrillation: the state of the science. Journal of Cardiovascular Nursing. 2010;25(1):40–51. doi: 10.1097/jcn.0b013e3181b7be36.
    1. Gehi A. K., Sears S., Goli N., et al. Psychopathology and symptoms of atrial fibrillation: implications for therapy. Journal of Cardiovascular Electrophysiology. 2012;23(5):473–478. doi: 10.1111/j.1540-8167.2011.02264.x.
    1. von Eisenhart Rothe A. F., Goette A., Kirchhof P., et al. Depression in paroxysmal and persistent atrial fibrillation patients: a cross-sectional comparison of patients enrolled in two large clinical trials. Europace. 2014;16(6):812–819. doi: 10.1093/europace/eut361.
    1. Thompson T. S., Barksdale D. J., Sears S. F., Mounsey J. P., Pursell I., Gehi A. K. The effect of anxiety and depression on symptoms attributed to atrial fibrillation. Pacing and Clinical Electrophysiology. 2014;37(4):439–446. doi: 10.1111/pace.12292.
    1. Camm A. J., Kirchhof P., Lip G. Y., et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European society of cardiology (ESC) Europace. 2010;12(10):1360–1420.
    1. Zigmond A. S., Snaith R. P. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica. 1983;67:361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Mystakidou K., Tsilika E., Parpa E., Katsouda E., Galanos A., Vlahos L. The hospital anxiety and depression scale in Greek cancer patients: psychometric analyses and applicability. Supportive Care in Cancer. 2004;12:821–825. doi: 10.1007/s00520-004-0698-y.
    1. Thrall G., Lip G. Y., Carroll D., Lane D. Depression, anxiety, and quality of life in patients with atrial fibrillation. Chest. 2007;132(4):1259–1264. doi: 10.1378/chest.07-0036.
    1. von Eisenhart Rothe A. F., Hutt F., Baumert J., et al. Depressed mood amplifies heart-related symptoms in persistent and paroxysmal atrial fibrillation patients: a longitudinal analysis–data from the German competence network on atrial fibrillation. Europace. 2015;17(9):1354–1362. doi: 10.1093/europace/euv018.
    1. von Eisenhart Rothe A. F., Bielitzer M., Meinertz T., Limbourg T., Ladwig K. H., Goette A. Predictors of discordance between physicians’ and patients’ appraisals of health-related quality of life in atrial fibrillation patients: findings from the angiotensin II antagonist in paroxysmal atrial fibrillation trial. American Heart Journal. 2013;166(3):589–596. doi: 10.1016/j.ahj.2013.05.020.
    1. Lane D. A., Langman C. M., Lip G. Y., Nouwen A. Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation. Journal of Psychosomatic Research. 2009;66(3):203–210. doi: 10.1016/j.jpsychores.2008.10.007.
    1. Pepine C. J. Effects of pharmacologic therapy on health-related quality of life in elderly patients with atrial fibrillation: a systematic review of randomized and nonrandomized trials. Clinical Medicine Insights Cardiology. 2013;7:1–20. doi: 10.4137/cmc.s10628.
    1. Trovato G. M., Pace P., Cangemi E., Martines G. F., Trovato F. M., Catalano D. Gender, lifestyles, illness perception and stress in stable atrial fibrillation. Clinical Therapeutics. 2012;163(4):281–286.
    1. Dabrowski R., Smolis-Bak E., Kowalik I., Kazimierska B., Wójcicka M., Szwed H. Quality of life and depression in patients with different patterns of atrial fibrillation. Kardiologia Polska. 2010;68(10):1133–1139.
    1. Ball J., Carrington M. J., Wood K. A., Stewart S. Women versus men with chronic atrial fibrillation: insights from the standard versus atrial fibrillation specific management study (SAFETY) PLoS One. 2013;8(5) doi: 10.1371/journal.pone.0065795.e65795
    1. Wändell P., Carlsson A. C., Gasevic D., Wahlsträm L., Sundquist J., Sundquist K. Depression or anxiety and all-cause mortality in adults with atrial fibrillation–a cohort study in Swedish primary care. Annals of Medicine. 2016;48(1-2):59–66. doi: 10.3109/07853890.2015.1132842.
    1. Benjamin E. J., Wolf P. A., D’Agostino R. B., Silbershatz H., Kannel W. B., Levy D. Impact of atrial fibrillation on the risk of death: the Framingham heart study. Circulation. 1998;98(10):946–952. doi: 10.1161/01.cir.98.10.946.
    1. Chatap G., Giraud K., Vincent J. P. Atrial fibrillation in the elderly: facts and management. Drugs & Aging. 2002;19(11):819–846. doi: 10.2165/00002512-200219110-00002.
    1. Wozakowska-kaplon B., Opolski G., Kosior D., Jaskulska-Niedziela E., Maroszynska-Dmoch E., Wlosowicz M. Cognitive disorders in elderly patients with permanent atrial fibrillation. Kardiologia Polska. 2009;67(5):487–493.
    1. Puccio D., Novo G., Baiamonte V., et al. Atrial fibrillation and mild cognitive impairment: what correlation? Minerva Cardioangiologica. 2009;57(2):143–150.
    1. Martin L. R., Williams S. L., Haskard K. B., DiMatteo M. R. The challenge of patient adherence. Therapeutics and Clinical Risk Management. 2005;1(3):189–199.
    1. Polikandrioti M., Goudevenos J., Michalis L. K., et al. Factors associated with depression and anxiety of hospitalized patients with heart failure. Hellenic Journal of Cardiology. 2015;56(1):26–35.
    1. Schnabel R. B., Michal M., Wilde S., et al. Depression in atrial fibrillation in the general population. PLoS One. 2013;8(12) doi: 10.1371/journal.pone.0079109.e79109
    1. McCabe P. J. What patients want and need to know about atrial fibrillation. Journal of Multidisciplinary Healthcare. 2011;4:413–419. doi: 10.2147/jmdh.s19315.
    1. Prasun M. A. Providing best practice in the management of atrial fibrillation in the United States. Journal of Cardiovascular Nursing. 2012;27(5):445–456. doi: 10.1097/jcn.0b013e318241736f.
    1. Polikandrioti M., Goudevenos J., Michalis L., et al. Correlation between the type of acute coronary syndrome with the needs of hospitalized patients. Global Journal of Health Science. 2015;8(7):126–134. doi: 10.5539/gjhs.v8n7p126.
    1. Patel D., Mc Conkey N. D., Sohaney R., Mc Neil A., Jedrzejczyk A., Armaganijan L. A. Systematic review of depression and anxiety in patients with atrial fibrillation: the mind-heart link. Cardiovascular Psychiatry and Neurology. 2013;2013:11. doi: 10.1155/2013/159850.159850

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться